SCHEMBL165508

SCHEMBL165508

Cc1csc(CNC(=O)c2c(C)ccc(C(=O)O)c2C)n1

nearest known ligand 0.55

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.55
NPC1 O15118 4/20 0.55
HSP90AA1 P07900 1/20 0.55
SORT1 Q99523 1/20 0.40
PDE10A Q9Y233 1/20 0.40
NAMPT P43490 1/20 0.39
ALDH1A1 P00352 2/20 0.38
LMNA P02545 1/20 0.38
SCD O00767 1/20 0.38
SLC5A7 Q9GZV3 1/20 0.38
SYK P43405 1/20 0.36
HTT P42858 1/20 0.36
MAPK1 P28482 1/20 0.36
MAPT P10636 1/20 0.35
GAA P10253 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL166268 0.89 RAB9A (0.54) RAB9ANPC1HSP90AA1PDE10ANAMPT
SCHEMBL166266 0.84 RAB9A (0.54) RAB9ANPC1HSP90AA1PDE10ANAMPT
SCHEMBL2711947 0.76 HPGD (0.56) RAB9ANPC1HSP90AA1PDE10ANAMPT
SCHEMBL2711084 0.75 NPC1 (0.58) RAB9ANPC1HSP90AA1NAMPTALDH1A1
SCHEMBL166870 0.74 ALDH1A1 (0.56) RAB9ANPC1SORT1ALDH1A1LMNA
SCHEMBL166396 0.72 NAMPT (0.48) RAB9ANPC1HSP90AA1NAMPTLMNA
SCHEMBL3507208 0.72 RAB9A (0.50) RAB9ANPC1HSP90AA1PDE10ANAMPT
SCHEMBL5178524 0.71 RAB9A (0.50) RAB9ANPC1HSP90AA1PDE10ANAMPT
SCHEMBL13024405 0.68 RAB9A (0.49) RAB9ANPC1HSP90AA1PDE10ANAMPT
SCHEMBL2201303 0.68 EGLN1 (0.62) NAMPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611441-A1 BACE INHIBITORS FOR USE IN THE TREATMENT OF DIABETES F.HOFFMANN-LA ROCHE AG (CH) 2013-07-10 EP disclosed
CN-103079562-A BACE inhibitors for use in the treatment of diabetes HOFFMANN LA ROCHE 2013-05-01 CN disclosed
WO-2012028563-A1 BACE INHIBITORS FOR USE IN THE TREATMENT OF DIABETES F. HOFFMANN-LA ROCHE AG (CH) 2012-03-08 WO disclosed